China SXT Pharmaceuticals
Quarterly Financials
| Values in thousands | 2026-06-30 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|
Revenue | $1,198 | $255 | $626 |
Gross Profit | 833 | 73 | 101 |
EBITDA | -672 | -371 | -6,306 |
EBIT | -784 | -392 | -6,338 |
Net Income | 163 | 81 | -6,368 |
Net Change In Cash | 1,198 | 255 | 626 |
Free Cash Flow | -2,264 | -1,132 | -1,752 |
Cash | 28,176 | 28,175 | 21,166 |
Basic Shares | 958 | 585 | 773 |
Annual Financials
| Values in thousands | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
Revenue | $1,072 | $1,740 | $1,928 | $1,971 |
Gross Profit | 183 | 367 | 553 | 426 |
EBITDA | -6,979 | -2,573 | -2,351 | -5,207 |
EBIT | -7,122 | -2,655 | -2,554 | -5,457 |
Net Income | -6,205 | -3,303 | -3,098 | -5,934 |
Net Change In Cash | 1,072 | 1,740 | 1,928 | 1,971 |
Free Cash Flow | -4,017 | -2,347 | -1,935 | -151 |
Cash | 28,176 | 18,099 | 12,070 | 17,368 |
Basic Shares | 679 | 403 | 867 | 266 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.05 |
2025-06-30 | -$1.02 |
2024-12-31 | -$1.99 |
2022-06-30 | -$2.03 |